MARION ELIZABETH SCOGGINS to Female
This is a "connection" page, showing publications MARION ELIZABETH SCOGGINS has written about Female.
Connection Strength
0.195
-
Screening Breast Ultrasound Following Tomosynthesis. Acad Radiol. 2022 03; 29(3):348-349.
Score: 0.024
-
Should abbreviated breast MRI be compliant with American College of Radiology requirements for MRI accreditation? Magn Reson Imaging. 2020 10; 72:87-94.
Score: 0.021
-
The Wire and Beyond: Recent Advances in Breast Imaging Preoperative Needle Localization. Radiographics. 2019 Nov-Dec; 39(7):1886-1906.
Score: 0.020
-
Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients. AJR Am J Roentgenol. 2015 Apr; 204(4):878-88.
Score: 0.015
-
Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol. 2013 Apr; 20(4):463-70.
Score: 0.013
-
Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. Radiographics. 2023 10; 43(10):e230034.
Score: 0.007
-
Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep. 2023 01 20; 13(1):1171.
Score: 0.006
-
Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm. AJR Am J Roentgenol. 2023 04; 220(4):512-523.
Score: 0.006
-
Tumor Immune Microenvironment Changes by Multiplex Immunofluorescence Staining in a Pilot Study of Neoadjuvant Talazoparib for Early-Stage Breast Cancer Patients with a Hereditary BRCA Mutation. Clin Cancer Res. 2022 09 01; 28(17):3669-3676.
Score: 0.006
-
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. J Magn Reson Imaging. 2022 12; 56(6):1901-1909.
Score: 0.006
-
Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of?Non-palpable Breast Lesions. Ann Surg Oncol. 2022 Jun; 29(6):3822-3828.
Score: 0.006
-
Reply to "Additional References Relevant to Preoperative Breast Lesion Localization Techniques". AJR Am J Roentgenol. 2022 03; 218(3):562.
Score: 0.006
-
The Challenging Image-Guided Preoperative Breast Localization: A Modality-Based Approach. AJR Am J Roentgenol. 2022 03; 218(3):423-434.
Score: 0.006
-
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection. Acad Radiol. 2022 07; 29(7):1039-1045.
Score: 0.006
-
BI-RADS Ultrasound Lexicon Descriptors and Stromal Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer. Acad Radiol. 2022 01; 29 Suppl 1:S35-S41.
Score: 0.006
-
Retained Localization Wire Fragments in the Breast: Long-term Follow-up. Curr Probl Diagn Radiol. 2022 May-Jun; 51(3):313-316.
Score: 0.006
-
Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer. 2021 08 15; 127(16):2880-2887.
Score: 0.006
-
Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol. 2021 Aug; 28(8):4277-4283.
Score: 0.005
-
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat. 2021 Jan; 185(1):1-12.
Score: 0.005
-
Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant. J Clin Oncol. 2020 02 10; 38(5):388-394.
Score: 0.005
-
American College of Radiology-Compliant Short Protocol Breast MRI for High-Risk Breast Cancer Screening: A Prospective Feasibility Study. AJR Am J Roentgenol. 2018 Jan; 210(1):214-221.
Score: 0.004
-
Pseudoangiomatous Stromal Hyperplasia of the Breast: Multimodality Review With Pathologic Correlation. Curr Probl Diagn Radiol. 2017 Mar - Apr; 46(2):130-135.
Score: 0.004
-
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol. 2016 Feb; 23(2):482-9.
Score: 0.004
-
Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat. 2013 Jun; 139(3):639-47.
Score: 0.003